Replies to post #267784 on Anavex Life Sciences Corp (AVXL)

[rayovacAAA]

NOTHING BAD ABOUT PATIENTS FROM THE A2-73 P2A AD TRIAL BEING ABLE TO CONTINUE TAKING A2-73 UNDER SAS CAT B APPROVAL!!!!!

More importantly, why is it bad that Anavex can/will make money/profits out of the SAS approval? It is good for the company, investors and most importantly..the patients (from treatment perspective and future cure/remedies perspective).